Search Results

Adenovirus Mediated Herpes Simplex Virus-Thymidine Kinase/Ganciclovir Gene Therapy for Resectable Malignant Glioma

Authors: Maatta, Ann-Marie; Samaranayake, Haritha; Pikkarainen, Jere; Wirth, Thomas; Yla-Herttuala, Seppo

Source: Current Gene Therapy, Volume 9, Number 5, October 2009 , pp. 356-367(12)

Publisher: Bentham Science Publishers

Non-viral targeted delivery system mediates transfection of thymidine kinase gene of herpes simplex virus into ovarian cancer cells: a comparison between one time and continuous mediation

Authors: Liu, Xiaojun; Jin, Zhijun; Xie, Kangyun; Huo, Xiaoxi; Zhang, Xinyan; Liu, Yan; Xu, Congjian

Source: The Chinese-German Journal of Clinical Oncology, Volume 7, Number 6, June 2008 , pp. 368-371(4)

Publisher: Springer

Effects of Bicistronic Lentiviral Vector-Mediated Herpes Simplex Virus Thymidine Kinase/Ganciclovir System on Human Lens Epithelial Cells

Authors: Yang, Jin; Liu, Tian Jin; Lu, Yi

Source: Current Eye Research, Volume 32, Number 1, January 2007 , pp. 33-42(10)

Publisher: Informa Healthcare

Exogenous wt-p53 enhances the antitumor effect of HSV-TK/GCV on C6 glioma cells

Authors: Huang, Qiang; Pu, Peiyu; Xia, Zhibo; You, Yongping

Source: Journal of Neuro-Oncology, Volume 82, Number 3, May 2007 , pp. 239-248(10)

Publisher: Springer

Gene therapy and uterine leiomyoma: a review

Authors: Al-Hendy, Ayman; Salama, Salama

Source: Human Reproduction Update, Volume 12, Number 4, July 2006 , pp. 385-400(16)

Publisher: Oxford University Press

Development of an HSV-tk transgenic mouse model for study of liver damage

Authors: Zhang, Yan; Huang, Shu-Zhen; Wang, Shu; Zeng, Yi-Tao

Source: FEBS Journal, Volume 272, Number 9, May 2005 , pp. 2207-2215(9)

Publisher: Blackwell Publishing

Enhanced efficacy of radiation-induced gene therapy in mice bearing lung adenocarcinoma xenografts using hypoxia responsive elements

Authors: Wang, Wei-dong; Chen, Zheng-tang; Li, Rong; Li, De-zhi; Duan, Yu-zhong; Cao, Zheng-huai

Source: Cancer Science, Volume 96, Number 12, December 2005 , pp. 918-924(7)

Publisher: Blackwell Publishing

Development of Prodrugs for Enzyme-Mediated, Tumor-Selective Therapy

Authors: K. J. Yoon; Philip M. Potter; Mary K. Danks

Source: Current Medicinal Chemistry - Anti-Cancer Agents, Volume 5, Number 2, March 2005 , pp. 107-113(7)

Publisher: Bentham Science Publishers

In Situ Gene Therapy for Prostate Cancer

Authors: Takefumi Satoh; Akira Irie; Shin Egawa; Shiro Baba

Source: Current Gene Therapy, Volume 5, Number 1, February 2005 , pp. 111-119(9)

Publisher: Bentham Science Publishers

MLV/HIV-pseudotyped vectors: a new treatment option for cutaneous t cell lymphomas

Authors: Thaler S.; Burger A.M.; Schulz T.; Schnierle B.S.

Source: Molecular Therapy, Volume 8, Number 5, November 2003 , pp. 756-761(6)

Publisher: Elsevier

Prodrugs in Genetic Chemoradiotherapy

Authors: Patterson, Adam V.; Saunders, Mark P.; Greco, Olga

Source: Current Pharmaceutical Design, Volume 9, Number 26, October 2003 , pp. 2131-2154(24)

Publisher: Bentham Science Publishers

Effect of trichostatin a and 5'-azacytidine on transgene reactivation in U937 transduced cells

Authors: Bartoli A.; Fettucciari K.; Fetriconi I.; Rosati E.; Ianni M.D.; Tabilio A.; Delfino D.V.; Rossi R.; Marconi P.

Source: Pharmacological Research, Volume 48, Number 1, July 2003 , pp. 111-118(8)

Publisher: Elsevier

In vitro thymidine kinase/ganciclovir-based suicide gene therapy using replication defective herpes simplex virus-1 against leukemic B-cell malignancies (MCL, HCL, B-CLL)

Authors: Misumi M.; Suzuki T.; Moriuchi S.; Glorioso J.C.; Bessho M.

Source: Leukemia Research, Volume 27, Number 8, August 2003 , pp. 695-699(5)

Publisher: Elsevier

Basic peptide system for efficient delivery of foreign genes

Authors: Kim H.H.; Lee W.S.; Yang J.M.; Shin S.

Source: Biochimica et Biophysica Acta (BBA)/Molecular Cell Research, Volume 1640, Number 2, 12 May 2003 , pp. 129-136(8)

Publisher: Elsevier

Development of a Therapeutic Adenoviral Vector for Cholangiocarcinoma Combining Tumor-Restricted Gene Expression and Infectivity Enhancement

Authors: Nagi P.; Vickers S.M.; Davydova J.; Adachi Y.; Takayama K.; Barker S.; Krasnykh V.; Curiel D.T.; Yamamoto M.

Source: Journal of Gastrointestinal Surgery, Volume 7, Number 3, March 2003 , pp. 364-371(8)

Publisher: Elsevier

Mutation of herpesvirus thymidine kinase to generate ganciclovir-specific kinases for use in cancer gene therapies

Authors: Mercer, Kelly E.; Ahn, Christina E.; Coke, Amanda; Compadre, Cesar M.; Drake, Richard R.

Source: Protein Engineering, Volume 15, Number 11, November 2002 , pp. 903-911(9)

Publisher: Oxford University Press

Adenovirus-mediated suicide-gene therapy in an orthotopic murine bladder tumor model

Authors: Cheon J.; Moon D.G.; Cho H.Y.; Park H.S.; Kim J.J.; Gardner T.A.; Kao C.

Source: International Journal of Urology, Volume 9, Number 5, May 2002 , pp. 261-267(7)

Publisher: Blackwell Publishing

Intracellular localization of Herpes simplex virus type 1 thymidine kinase fused to different fluorescent proteins depends on choice of fluorescent tag

Authors: Soling A.; Simm A.; Rainov N.G.

Source: FEBS Letters, Volume 527, Number 1, 11 September 2002 , pp. 153-158(6)

Publisher: Elsevier

Influence of the Bystander Effect on HSV-tk / GCV Gene Therapy. A Review.

Authors: van Dillen I.J.; Mulder N.H.; Vaalburg W.; de Vries E.F.J.; Hospers G.A.P.

Source: Current Gene Therapy, Volume 2, Number 3, September 2002 , pp. 307-322(16)

Publisher: Bentham Science Publishers

A combined gene delivery by co-transduction of adenoviral and retroviral vectors for cancer gene therapy

Authors: Pan Y.; Zhai P.; Dashti A.M.; Wu S.; Lin X.; Wu M.

Source: Cancer Letters, Volume 184, Number 2, 28 October 2002 , pp. 179-188(10)

Publisher: Elsevier